Form D · Biotechnology
InVivo Therapeutics Corp
Cambridge, MA · CIK 0001500550
Offering snapshot reported Sep 3, 2010 · SEC filing
- Reported sold
- $300K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 12, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2010 | Initial | $300,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-147272
Spencer Trask Ventures, Inc. is receiving a warrant for 20% of the shares issuable upon exercise of the warrants sold to investors
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None | Spencer Trask Ventures, Inc. · CRD 28373 |
Source: Form D, filed Sep 3, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean F Moran | Executive |
| George Nolen | Director |
| Christi M Pedra | Director |
| Christopher Pritchard | Executive |
| Frank M Reynolds | Director, Executive |
| Richard J Roberts | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Broadway, 14 Th Floor
Cambridge, MA, 02142
Cambridge, MA, 02142